Cyclothiazomycin

Last updated
Cyclothiazomycin
Cyclothiazomycin-A.png
Names
Other names
cyclothiazomycin A, 5102-II
Identifiers
3D model (JSmol)
PubChem CID
  • InChI=1S/C59H64N18O14S7/c1-7-27-47(85)76-59(6)58(91)75-42(25(5)78)49(87)61-15-40(80)64-28(8-2)56(88)77-13-9-10-38(77)48(86)62-23(3)41-26(43(81)67-30(14-39(60)79)52-69-32(17-93-52)45(83)66-27)11-12-29(65-41)51-73-35(20-96-51)53-70-31(16-94-53)44(82)63-24(4)50-72-34(19-92-50)55-74-36(21-97-55)54-71-33(18-95-54)46(84)68-37(22-98-59)57(89)90/h7-8,11-12,19-21,23,25,30-33,37-38,42,78H,4,9-10,13-18,22H2,1-3,5-6H3,(H2,60,79)(H,61,87)(H,62,86)(H,63,82)(H,64,80)(H,66,83)(H,67,81)(H,68,84)(H,75,91)(H,76,85)(H,89,90)/b27-7-,28-8-/t23-,25-,30+,31+,32+,33-,37+,38+,42+,59+/m1/s1
    Key: OGUUCNCVZHZWGA-CRYGVMHLSA-N
  • O=C([C@H]1CSC(C2=CSC(C3=CSC(C(NC([C@@H]4CSC(C5=CSC(C6=CC=C(C(N[C@@H](CC(N)=O)C7=N[C@H](C(N/C8=C\C)=O)CS7)=O)C([C@H](NC9=O)C)=N6)=N5)=N4)=O)=C)=N3)=N2)=N1)N[C@H](C(O)=O)CS[C@@](C)(C(N[C@]([C@H](O)C)([H])C(NCC(N/C(C(N%10[C@H]9CCC%10)=O)=C\C)=O)=O)=O)NC8=O
Properties
C59H64N18O14S7
Molar mass 1473.71 g/mol
Melting point >210 °C (decomposes)
Solubility soluble in water, chloroform/methanol, mixed aqueous/organic solvents (DMSO/water, methanol/water, acetone/water)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN (what is  Yes check.svgYX mark.svgN ?)

The cyclothiazomycins are a group of natural products, classified as thiopeptides, which are produced by various Streptomyces species of bacteria.

Contents

These compounds are ribosomally synthesized and post-translationally modified peptides (RiPPs) and can be further classified as thiopeptides. The overall structure of the cyclothiazomycins comprises a macrocyclic bicyclic peptide containing several thiazoles and thiazolines. The cyclothiazomycins are reported to have multiple inhibitory effects ranging from decreasing blood pressure to interfering with RNA transcription; they also exhibit some antibiotic activity.

History

Cylothiazomycin A was first isolated from Streptomyces sp. NR0516 in 1991. [1] The structure of cyclothiazomycin A was solved via NMR spectroscopy and chemical degradation. [2] Previously, a peptide compound 5102-II had been isolated in 1982 from Streptomyces hygroscopicus 10-22. [3] The discovery of the genes responsible for the biosynthesis of cyclothiazomycin in 2010 showed that 5102-II and cyclothiazomycin A were the same compound. [4]

Structural analogues cyclothiazomycin B1 and B2 were isolated from Streptomyces sp. A307 and solved in 2006 with the help of high-resolution mass spectrometry and NMR spectroscopy. [5]

A third analogue, cyclothiazomycin C, was discovered in 2014 with the aid of genome mining, nucleophilic 1,4-addition labeling reactions, high resolution mass spectrometry, and NMR spectroscopy. [6]

Structure

The cyclothiazomycins are thiazole-containing bicyclic and macrocyclic peptides that are structurally similar to thiostrepton and noshiheptide. [2] Formally classified as thiopeptides within the larger family of ribosomally synthesized and post-translationally modified peptides (RiPPs), the cyclothiazomycins are initially biosynthesized as peptides which subsequently undergo chemical modifications, including macrocyclization, aromatization, cyclodehydration, and dehydrogenation. Cyclothiazomycins exist as three analogues that differ at two amino acid residues in the core peptide. The image below denotes in red the differences between the analogues as well as the amino acid sequence that becomes the final compounds.[ citation needed ]

The structure of cyclothiazomycin A was established primarily by two-dimensional nuclear magnetic resonance spectroscopy. Cyclothiazomycin A contains a dehydroalanine and two dehydrohomoalanine residues within a bicyclic, macrocyclic scaffold composed of thiazolines, thiazoles, and a trisubstituted pyridine. [2]

Cyclothiazomycin B and C vary from cyclothiazomycin A at the second and third threonine residues in the core sequence of the precursor peptide. In cyclothiazomycin B, the second threonine is an arginine. Cyclothiazomycin B exists as a pair of diastereomers, cyclothiazomycin B1 and cyclothiazomycin B2, that differ at the configuration of one of its dehydrohomoalanine moieties. Cyclothiazomycin B1 and B2 interconvert by isomerization in solution but are stable in the solid state. [5]

Cyclothiazomycin C has a lysine in place of the second threonine residue found in cyclothiazomycin A and a serine residue in place of the third threonine residue, resulting in a dehydroalanine instead of the dehydrohomoalanine observed in cyclothiazomycin A. [6]

The cyclothiazomycin family of antibiotics includes cyclothiazomycins A, B, and C. The structural differences between the analogues are shown in red. Also depicted are the sequences of the peptides that are chemically modified to become the final molecules. Cyclothiazomycin-family.png
The cyclothiazomycin family of antibiotics includes cyclothiazomycins A, B, and C. The structural differences between the analogues are shown in red. Also depicted are the sequences of the peptides that are chemically modified to become the final molecules.

Biosynthesis

Cyclothiazomycin family gene clusters. Gene names are found above and below genes. The varying nomenclature is due to differing understanding of gene purpose. Gene Cluster for Cyclothiazomycin Family.png
Cyclothiazomycin family gene clusters. Gene names are found above and below genes. The varying nomenclature is due to differing understanding of gene purpose.

Cyclothiazomycin is part of a class of natural products that are ribosomally synthesized and post-translationally modified peptides (RiPPs). As such, cyclothiazomycin begins as a peptide that is synthesized in the bacterial ribosome. A series of chemical steps by biosynthetic enzymes transform the original peptide into the final (mature) natural product.[ citation needed ]

The gene encoding for cyclothiazomycin begins with a short open reading frame (ORF) ctmA (cltA). CtmD (cltB) encodes a "fused" TOMM cyclodehydratase believed to take part in the formation of thiazolines. The enzyme encoded by the ctmB (cltC) gene is believed to catalyze the dehydrogenation of thiazolines to thiazoles. CtmE and ctmF (ctlE and cltF) each encode a split lanthipeptide dehydratase which dehydrates serine and threonine to dehydroalanine and dehydrobutyrine. CtmG (cltG) is believed to aide in the production of the central pyridine. CtmI (cltD) encodes a ThiF-like protein. CtmH (cltH) is a LuxR-type regulatory gene. CtmJK are not present in the cycloythiazomycin A and C clusters; there is no known function. The cltN gene is believed to encode an enzyme that is involved in the formation of the tertiary thioether, however this has not been proven and cltN is not regulated by ctmH.CtmA, ctmD, ctmF, and ctmG deletion leads to the disappearance of cyclothiazomycin A. [3] [4] [7]

CtmH is a LuxR-type regulatory gene that was shown to regulate ctmA-ctmL. [7]

Bioactivity

Each analogue of cyclothiazomycin is believed to interact with at least one biological target. Cyclothiazomycin A has been shown to inhibit blood plasma renin leading to a decrease blood pressure; it also exhibits weak anti-fungal activity. [1] [3] Cyclothiazomycin B shows inhibitory activity against RNA polymerase, and it is believed to act by reducing ribosome dependent GTPase. [5] Cyclothiazomycin B also exhibits anti-fungal activity by binding to the chitin of cell walls, thus producing a fragile cell wall. [8] Recently discovered cyclothiazomycin C has an unknown biological role, but cyclothiazomycins B and C both exhibit antibacterial activity against Gram-positive bacteria, including Bacillus anthracis . [6]

Related Research Articles

<span class="mw-page-title-main">Nisin</span> Chemical compound

Nisin is a polycyclic antibacterial peptide produced by the bacterium Lactococcus lactis that is used as a food preservative. It has 34 amino acid residues, including the uncommon amino acids lanthionine (Lan), methyllanthionine (MeLan), didehydroalanine (Dha), and didehydroaminobutyric acid (Dhb). These unusual amino acids are introduced by posttranslational modification of the precursor peptide. In these reactions a ribosomally synthesized 57-mer is converted to the final peptide. The unsaturated amino acids originate from serine and threonine, and the enzyme-catalysed addition of cysteine residues to the didehydro amino acids result in the multiple (5) thioether bridges.

Nonribosomal peptides (NRP) are a class of peptide secondary metabolites, usually produced by microorganisms like bacteria and fungi. Nonribosomal peptides are also found in higher organisms, such as nudibranchs, but are thought to be made by bacteria inside these organisms. While there exist a wide range of peptides that are not synthesized by ribosomes, the term nonribosomal peptide typically refers to a very specific set of these as discussed in this article.

<span class="mw-page-title-main">Clavulanic acid</span> Β-lactam molecule used as β-lactamase inhibitor to overcome antibiotic resistance in bacteria

Clavulanic acid is a β-lactam drug that functions as a mechanism-based β-lactamase inhibitor. While not effective by itself as an antibiotic, when combined with penicillin-group antibiotics, it can overcome antibiotic resistance in bacteria that secrete β-lactamase, which otherwise inactivates most penicillins.

<span class="mw-page-title-main">Daptomycin</span> Antibiotic

Daptomycin, sold under the brand name Cubicin among others, is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.

<span class="mw-page-title-main">Geldanamycin</span> Chemical compound

Geldanamycin is a 1,4-benzoquinone ansamycin antitumor antibiotic that inhibits the function of Hsp90 by binding to the unusual ADP/ATP-binding pocket of the protein. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis.

<span class="mw-page-title-main">Renin inhibitor</span> Compound inhibiting the activity of renin

Renin inhibitors are pharmaceutical drugs inhibiting the activity of renin that is responsible for hydrolyzing angiotensinogen to angiotensin I, which in turn reduces the formation of angiotensin II that facilitates blood pressure.

<span class="mw-page-title-main">Thiostrepton</span> Chemical compound

Thiostrepton is a natural cyclic oligopeptide antibiotic of the thiopeptide class, derived from several strains of streptomycetes, such as Streptomyces azureus and Streptomyces laurentii. Thiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide (RiPP) class.

Zwittermicin A is an antibiotic that has been identified from the bacterium Bacillus cereus UW85. It is a molecule of interest to agricultural industry because it has the potential to suppress plant disease due to its broad spectrum activity against certain gram positive and gram negative prokaryotic micro-organisms. The molecule is also of interest from a metabolic perspective because it represents a new structural class of antibiotic and suggests a crossover between polyketide and non-ribosomal peptide biosynthetic pathways. Zwittermicin A is linear aminopolyol.

Streptogramin A is a group of antibiotics within the larger family of antibiotics known as streptogramins. They are synthesized by the bacteria Streptomyces virginiae. The streptogramin family of antibiotics consists of two distinct groups: group A antibiotics contain a 23-membered unsaturated ring with lactone and peptide bonds while group B antibiotics are depsipeptides. While structurally different, these two groups of antibiotics act synergistically, providing greater antibiotic activity than the combined activity of the separate components. These antibiotics have until recently been commercially manufactured as feed additives in agriculture, although today there is increased interest in their ability to combat antibiotic-resistant bacteria, particularly vancomycin-resistant bacteria.

Streptogramin B is a subgroup of the streptogramin antibiotics family. These natural products are cyclic hexa- or hepta depsipeptides produced by various members of the genus of bacteria Streptomyces. Many of the members of the streptogramins reported in the literature have the same structure and different names; for example, pristinamycin IA = vernamycin Bα = mikamycin B = osteogrycin B.

Thiazolines are a group of isomeric 5-membered heterocyclic compounds containing both sulfur and nitrogen in the ring. Although unsubstituted thiazolines are rarely encountered themselves, their derivatives are more common and some are bioactive. For example, in a common post-translational modification, cysteine residues are converted into thiazolines.

Plantazolicin (PZN) is a natural antibiotic produced by the gram-positive soil bacterium Bacillus velezensis FZB42. PZN has specifically been identified as a selective bactericidal agent active against Bacillus anthracis, the causative agent of anthrax. This natural product is a ribosomally synthesized and post-translationally modified peptide (RiPP); it can be classified further as a thiazole/oxazole-modified microcin (TOMM) or a linear azole-containing peptide (LAP).

<span class="mw-page-title-main">Bottromycin</span> Chemical compound

Bottromycin is a macrocyclic peptide with antibiotic activity. It was first discovered in 1957 as a natural product isolated from Streptomyces bottropensis. It has been shown to inhibit methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among other Gram-positive bacteria and mycoplasma. Bottromycin is structurally distinct from both vancomycin, a glycopeptide antibiotic, and methicillin, a beta-lactam antibiotic.

Ribosomally synthesized and post-translationally modified peptides (RiPPs), also known as ribosomal natural products, are a diverse class of natural products of ribosomal origin. Consisting of more than 20 sub-classes, RiPPs are produced by a variety of organisms, including prokaryotes, eukaryotes, and archaea, and they possess a wide range of biological functions.

Teixobactin is a peptide-like secondary metabolite of some species of bacteria, that kills some gram-positive bacteria. It appears to belong to a new class of antibiotics, and harms bacteria by binding to lipid II and lipid III, important precursor molecules for forming the cell wall.

<span class="mw-page-title-main">Nosiheptide</span> Chemical compound

Nosiheptide is a thiopeptide antibiotic produced by the bacterium Streptomyces actuosus.

<span class="mw-page-title-main">Thiopeptide</span> Class of peptide antibiotics

Thiopeptides are a class of peptide antibiotics produced by bacteria. They have antibiotic activity against Gram-positive bacteria, but little or no activity against Gram-negative bacteria. Many of the members of this class show activity against methicillin-resistant Staphylococcus aureus (MRSA) and are therefore subjects of research interest.

Butyrolactol A is an organic chemical compound of interest for its potential use as an antifungal antibiotic.

<span class="mw-page-title-main">Klebsazolicin</span> Chemical compound

Klebsazolicin (KLB) is a peptide antibiotic encoded in the genome of a gram-negative bacterium Klebsiella pneumoniae subsp. ozonae and targeting prokaryotic ribosome. Klebsazolicin is a ribosomally synthesized and post-translationally modified peptide (RiPP) and a linear azol(in)e-containing peptide (LAP).

<span class="mw-page-title-main">Cinnamycin</span> Cinnamycin is a type B lantibiotic produced by Streptomyces cinnamoneus

Cinnamycin is a tetracyclic antibacterial peptide produced by Streptomyces cinnamoneus containing 19 amino acid residues including the unusual amino acids threo-3-methyl-lanthionine, meso-lanthionine, lysinoalanine, and 3-hydroxyaspartic acid.

References

  1. 1 2 Aoki, M; Ohtsuka, T; Yamada, M; Ohba, Y; Yoshizaki, H; Yasuno, H; Sano, T; Watanabe, J; Yokose, K; Seto, H (Jun 1991). "Cyclothiazomycin, a novel polythiazole-containing peptide with renin inhibitory activity. Taxonomy, fermentation, isolation and physico-chemical characterization". The Journal of Antibiotics. 44 (6): 582–8. doi: 10.7164/antibiotics.44.582 . PMID   2071486.
  2. 1 2 3 Aoki, Masahiro; Ohtsuka, Tatsuo; Itezono, Yoshiko; Yokose, Kazuteru; Furihata, Kazuo; Seto, Haruo (1991). "Structure of cyclothiazomycin, a unique polythiazole-containing peptide with renin inhibitory activity. Part 2. Total structure". Tetrahedron Letters. 32 (2): 221–224. doi:10.1016/0040-4039(91)80860-9.
  3. 1 2 3 Zhang, S.; Zhau, H; Liu, J (1982). "Studies on the agricultural antibiotics 5102-II. isolation and characterization of antibiotic 5102-II". Acta Microbiologica Sinica. 22: 145–150.
  4. 1 2 3 Wang, J.; Yu, Y.; Tang, K.; Liu, W.; He, X.; Huang, X.; Deng, Z. (12 February 2010). "Identification and Analysis of the Biosynthetic Gene Cluster Encoding the Thiopeptide Antibiotic Cyclothiazomycin in Streptomyces hygroscopicus 10-22". Applied and Environmental Microbiology. 76 (7): 2335–2344. doi:10.1128/AEM.01790-09. PMC   2849233 . PMID   20154110.
  5. 1 2 3 Hashimoto, Masaru; Murakami, Takanori; Funahashi, Katsuyuki; Tokunaga, Takashi; Nihei, Ken-ichi; Okuno, Toshikatsu; Kimura, Takatsugu; Naoki, Hideo; Himeno, Hyouta (2006). "An RNA polymerase inhibitor, cyclothiazomycin B1, and its isomer". Bioorganic & Medicinal Chemistry. 14 (24): 8259–8270. doi:10.1016/j.bmc.2006.09.006. PMID   17010619.
  6. 1 2 3 4 Cox, Courtney L.; Tietz, Jonathan I.; Sokolowski, Karol; Melby, Joel O.; Doroghazi, James R.; Mitchell, Douglas A. (17 June 2014). "Nucleophilic 1,4-Additions for Natural Product Discovery". ACS Chemical Biology. 9 (9): 2014–2022. doi:10.1021/cb500324n. PMC   4168802 . PMID   24937678.
  7. 1 2 Zhang, P.; Wu, H.; Chen, X.-L.; Deng, Z.; Bai, L.; Pang, X. (25 April 2014). "Regulation of the biosynthesis of thiopeptide antibiotic cyclothiazomycin by the transcriptional regulator SHJG8833 in Streptomyces hygroscopicus 5008". Microbiology. 160 (Pt_7): 1379–1392. doi: 10.1099/mic.0.076901-0 . PMID   24769844.
  8. Mizuhara, Naoko; Kuroda, Manabu; Ogita, Akira; Tanaka, Toshio; Usuki, Yoshinosuke; Fujita, Ken-ichi (2011). "Antifungal thiopeptide cyclothiazomycin B1 exhibits growth inhibition accompanying morphological changes via binding to fungal cell wall chitin". Bioorganic & Medicinal Chemistry. 19 (18): 5300–5310. doi:10.1016/j.bmc.2011.08.010. PMID   21885289.